We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

NasdaqGM - Nasdaq Real Time Price USD

Denali Capital Acquisition Corp. (DECAW)

0.0599

-0.0045

(-6.99%)

As of 9:38:41 AM EST. Market Open.

Key Events

Loading Chart for DECAW

9/21 12:03 PM

DELL

Previous Close 0.0644
Open 0.0599
Bid --
Ask --
Day's Range 0.0599 - 0.0599
52 Week Range 0.0599 - 0.0599
Volume 10,000
Avg. Volume --
Market Cap (intraday) --
Beta (5Y Monthly) 0.33
PE Ratio (TTM) --
EPS (TTM) --
Earnings Date --
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Denali Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. It intends to complete a business combination with companies primarily operating in the technology, consumer services, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York.

--

Full Time Employees

--

Fiscal Year Ends

Financial Services

Sector

Shell Companies

Industry

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and Denali

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and Denali

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 Billion

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 Billion

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination

Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination

Top Midday Gainers

Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Denali Capital Acquisition Corp.

0.0599

-6.99%

Mkt Cap -

Industry Shell Companies

SK Growth Opportunities Corporation

11.66

+0.04%

Mkt Cap 174.51M

Industry Shell Companies

Valuation Measures

    Annual 

As of

Market Cap

--
Enterprise Value

--
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

--
Price/Book (mrq)

--
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-1.09%
Return on Equity (ttm)

--
Revenue (ttm)

--
Net Income Avi to Common (ttm)

1.9M
Diluted EPS (ttm)

--

Balance Sheet and Cash Flow

Total Cash (mrq)

1.5k
Total Debt/Equity (mrq)

--
Levered Free Cash Flow (ttm)

-235.21k

DECAW does not have Company Insights

DECA Denali Capital Acquisition Corp.

12.00

+0.59%

BNIXW Bannix Acquisition Corp.

0.0310

0.00%

CLRCW ClimateRock

0.0224

-5.49%

EVGRW Evergreen Corporation

0.0439

0.00%

DAVEW Dave Inc.

0.2900

+1.04%

CELUW Celularity Inc.

0.0699

+14.40%

SCLXW Scilex Holding Company

0.1799

-0.06%

FTIIW FutureTech II Acquisition Corp.

0.0288

0.00%

DFLIW Dragonfly Energy Holdings Corp.

0.0299

+8.33%

DRMAW Dermata Therapeutics, Inc.

0.0288

-3.68%

GATEW Marblegate Acquisition Corp.

0.0500

+13.64%

CMPOW CompoSecure, Inc.

4.8200

+2.77%

DRTSW Alpha Tau Medical Ltd.

0.3000

0.00%

DISTW Distoken Acquisition Corporation

0.0160

-0.62%

GBBKW Global Blockchain Acquisition Corp.

0.0595

+64.82%

WAVSW Western Acquisition Ventures Corp.

0.0890

0.00%